A “Do No Harm” novel safety checklist and research approach to determine whether to launch an artificial intelligence-based medical technology: introducing the Biological-Psychological, Economic, and Social (BPES) framework
Open accessPublished version of a preprint
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Given the impact artificial intelligence (AI)–based medical technologies (hardware devices, software programs, and mobile apps) can have on society, debates regarding the principles behind their development and deployment are emerging. Using the biopsychosocial model applied in psychiatry and other fields of medicine as our foundation, we propose a novel 3-step framework to guide industry developers of AI-based medical tools as well as health care regulatory agencies on how to decide if a product should be launched—a “Go or No-Go” approach. More specifically, our novel framework places stakeholders’ (patients, health care professionals, industry, and government institutions) safety at its core by asking developers to demonstrate the biological-psychological (impact on physical and mental health), economic, and social value of their AI tool before it is launched. We also introduce a novel cost-effective, time-sensitive, and safety-oriented mixed quantitative and qualitative clinical phased trial approach to help industry and government health care regulatory agencies test and deliberate on whether to launch these AI-based medical technologies. To our knowledge, our biological-psychological, economic, and social (BPES) framework and mixed method phased trial approach are the first to place the Hippocratic Oath of “Do No Harm” at the center of developers’, implementers’, regulators’, and users’ mindsets when determining whether an AI-based medical technology is safe to launch. Moreover, as the welfare of AI users and developers becomes a greater concern, our framework’s novel safety feature will allow it to complement existing and future AI reporting guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“While the Biological-Psychological, Economic, and Social checklist by Khan and Seto [32] covers the planning aspect of AI development, it does not go beyond that phase, which is a limitation in its application.”
From Checklist Approach to Developing and Implementing AI in Clinical Settings: Instrument Development Study (2025) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dissecting racial bias in an algorithm used to manage the health of populations
Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019) · Science · doi:10.1126/science.aax2342 · Cited by 7,137 · cited 2×
“For example, at a given risk score, Black patients were found to be significantly sicker than White patients in most active chronic illnesses [23].”
The global landscape of AI ethics guidelines
Jobin, A., Ienca, M., & Vayena, E. (2019) · Nature Machine Intelligence · doi:10.1038/s42256-019-0088-2 · Cited by 6,220
Rajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212 · cited 3×
“Nevertheless, AI is now being used to accelerate the process of drug discovery by using deep learning model analysis that reduces the dependency on slower and expensive physical experiments [20].”
InfluentialPrinciples of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Artificial intelligence in healthcare
Yu, K.-H., Beam, A. L., & Kohane, I. S. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0305-z · Cited by 2,817
Clinically applicable deep learning for diagnosis and referral in retinal disease
De Fauw, J., Ledsam, J. R., Romera-Paredes, B., Nikolov, S., Tomasev, N., Blackwell, S., Askham, H., Glorot, X., O’Donoghue, B., Visentin, D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0107-6 · Cited by 2,639
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A. M., Rajmane, A., Cheung, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901183 · Cited by 1,917
Implementing Machine Learning in Health Care — Addressing Ethical Challenges
Char, D. S., Shah, N. H., & Magnus, D. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1714229 · Cited by 1,857 · cited 1×
“Private-sector AI medical technology companies might also be subject to similar temptations, especially when reimbursement rates are based on metrics that do not always reflect better care [3].”
Fullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., Abdela, J., Abdelalim, A., Abebe, Z., Abebo, T. A., Aboyans, V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30994-2 · Cited by 1,013 · cited 1×
“However, providing access to affordable quality of care is often viewed as a leading objective in improving medical outcomes in a health care system [26].”
Cited by
Opportunities and risks of large language models in psychiatry
Obradovich, N., Khalsa, S. S., Khan, W. U., Suh, J., Perlis, R. H., Ajilore, O., & Paulus, M. P. (2024) · NPP—Digital Psychiatry and Neuroscience · doi:10.1038/s44277-024-00010-z · Cited by 79
Self-citationGyevnár, B., & Kasirzadeh, A. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-01020-y · Cited by 86
New trend in artificial intelligence-based assistive technology for thoracic imaging
Yanagawa, M., Ito, R., Nozaki, T., Fujioka, T., Yamada, A., Fujita, S., Kamagata, K., Fushimi, Y., Tsuboyama, T., Matsui, Y., et al. (2023) · La radiologia medica · doi:10.1007/s11547-023-01691-w · Cited by 36
Owoyemi, A., Osuchukwu, J., Salwei, M. E., & Boyd, A. (2025) · JMIRx Med · doi:10.2196/65565 · Cited by 18
“While the Biological-Psychological, Economic, and Social checklist by Khan and Seto [32] covers the planning aspect of AI development, it does not go beyond that phase, which is a limitation in its application.”
A Risk Ontology for Evaluating AI-Powered Psychotherapy Virtual Agents
Steenstra, I., & Bickmore, T. (2025) · ACM International Conference on Intelligent Virtual Agents (IVA) · doi:10.1145/3717511.3749286 · Cited by 17
Ferrarini, F., & Leonelli, S. (2025) · Industrial Management & Data Systems · doi:10.1108/imds-05-2025-0661 · Cited by 8
Envisioning Possibilities and Challenges of AI for Personalized Cancer Care
Kong, E. W. S., Huang, K., & Gautam, A. (2024) · ACM Conference on Computer Supported Cooperative Work (CSCW) · doi:10.1145/3678884.3681885 · Cited by 6
Responsible artificial intelligence integration framework for psychiatric guidelines
Mendlovic, S., Frankova, I., Vermetten, E. H. G. J. M., Wasserman, D., Schulze, T. G., Falkai, P., Fountoulakis, K. Ν., Adorjan, K., Uchida, H., Fruchter, E., et al. (2026) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyag010 · Cited by 4
A Review of AI-Driven Mental Health Interventions in the United States: Gaps and Opportunities
Akintoye, O. S., Maale, F. D., Yusuf, R. A., & Odondi, A. A. (2023) · Journal of Frontiers in Multidisciplinary Research · doi:10.54660/.jfmr.2023.4.1.446-457 · Cited by 2
Responsible AI Integration Framework for Psychotherapy
Mendlovic, S. (2025) · BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE · doi:10.70594/brain/16.4/26 · Cited by 1
Applications of machine learning and deep learning in medical diagnosis
Chouhan, S., Khambete, H., & Jain, S. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21505-6.00003-7 · Cited by 1
Deletion Isn't Enough: Auditing RAG for Selective Forgetting
Tavakoli, L., & Sanderson, M. (2026) · Proceedings of the 49th International ACM SIGIR Conference on Research and Development in Information Retrieval · doi:10.1145/3805712.3808545
Three-dimensional Digital Reconstruction and Application of AR_MR Technology in Medicine
Su, X. M., & Chen, N. (2023) · Automation and Machine Learning · doi:10.23977/autml.2023.040202
The Rise of the Machines: Artificial Intelligence in Ophthalmology - A Boon or Bane?
Yılmaz, İ. E. (2024) · Gaziantep Islam Science and Technology University · doi:10.46871/eams.1456762
LipidLlama: A Multilingual AI Chatbot for Personalized Cardiovascular Risk Assessment
Smith, T., Karnik, A., Hourmozdi, J., Thomas, J., & Kline, A. S. (2025) · ConductScience Journal · doi:10.55157/csj.v2i1.3
Artificial intelligence is not fulfilling the “Do No Harm” principle in oncology: A mini review
Odeh, Y., & Abdallah, M. (2026) · AIP conference proceedings · doi:10.1063/5.0318277
Alzughbi, H., Park, J., & Knijnenburg, B. P. (2026) · International Journal of Human-Computer Studies · doi:10.2139/ssrn.6235653
AI Innovation, Safety, and Regulation in Canada: Perspectives from the Editorial Committee
Sen, A., Clarke, A., Morales, J. S., Penney, J. W., & Scassa, T. (2026) · Canadian Public Policy · doi:10.3138/cpp.2025-066
Ethical and Legal Implications in Medical AI
Khullar, S., Ahmed, I., Kapoor, S. K., Joshi, M. L., & Arora, A. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-2600-2173-6.ch005
Metadata
- Authors
- Khan, W. U., & Seto, E.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Khan, Waqas Ullah
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2023-04-05
- Volume
- 25
- Pages
- e43386
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC10131977
- OpenAlex
- W4323911815
- Cited by
- 15
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 3 · 2023: 2
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Ethics and Social Impacts of AI
- Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Safety Systems Engineering in Autonomy
- Keywords
- artificial intelligence in healthcare, product launch decisions, safety checklist, do no harm principle, biopsychosocial model, health care regulation
- MeSH terms
- Artificial Intelligence, Government, Government Agencies, Humans, Checklist, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.